Egflam - EGF-like, fibronectin type III and laminin G domains

Predicted to enable glycosaminoglycan binding activity. Predicted to be involved in animal organ morphogenesis and tissue development. Predicted to act upstream of or within extracellular matrix organization; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; and positive regulation of cell-substrate adhesion. Predicted to be located in cell surface and interstitial matrix. Predicted to be active in basement membrane. Orthologous to human EGFLAM (EGF like, fibronectin type III and laminin G domains). [provided by Alliance of Genome Resources, Apr 2022]